Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical.

Slides:

Advertisements

Similar presentations

MANAGEMENT OF ABNORMAL PAP SMEAR

Advertisements

MANAGEMENT OF THE ABNORMAL PAP SMEAR

Updates on Pap Smear Guidelines 2014

COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.

PRE-INVASIVE DISEASE OF THE CERVIX CERVICAL INTRAEPHELIAL NEOPLASIA DR. AMEL AL-SAYED Asst. Prof. & Consultant Ob/Gyne Dept.

Case Presentations: Pre-Invasive Cervical Neoplasia

Cervical Cancer Screening

SoftPAP® A Novel Collection Device for Cervical Cytology.

Current guidelines for Cervical Cancer Screening

In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.

CERVICAL/VAGINAL CYTOLOGY

AGE DIFFERENCE IN CERVICAL NEOPLASIA DISTRIBUTION AMONG WOMEN ATTENDING A HOSPITAL BASED AND PERIPHERAL SCREENING PROGRAMMES Dr.Kalavathy Mathurchennath1,

Cervical Intraepithelial Neoplasm

1 Cytology Cases September 10, Thinprep Pap (28 year old) A. AGC B. Reactive Endocervical Cells C. Atrophy D. HSIL E. Endometrial.

2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.

Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.

Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.

Discussion & Conclusion

Public Health England leads the NHS Screening Programmes

Fig. 1. Framework of developing a guideline for cervical cancer screening. ① Benefits of pap test screening, ② harms of pap test screening, ③ accuracy.

Montana Academy of PAs CME conference Elyse Watkins, DHSc, MS, PA-C

Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,

NEW SCREENING PROTOCOL WITH DUAL-STAINED CYTOLOGY TRIAGE

Trreatment of Preinvasive Lesions

Cost-effectiveness Analysis for Cervical Cancer Screening Using HPV DNA Tests in Chile Franco Figueira S, BPharm student1; Cachoeira CV, MD, MBA1; Silva.

Concentration Levels of IL -10 and TNF-α Cytokines in Patients with HPV DNA Positive and Negative Cervical Lesions* Katan Sabir Ali *, Husham Y.

Lichen sclerosus and Lichen planus and risk for malignancy

Preinvasive Cervical Neoplasia

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment Allan Hildesheim,

Cervical Cancer Colposcopy & Treatment

Bibliometric Analysis of Human Papillomavirus Research

From: Inefficiencies and High-Value Improvements in U. S

Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.

Various types of cervical lesions as seen on Pap smears:

Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.

Copyright © 2015 by the American Osteopathic Association.

HPV Tajossadat Allameh Associated Profeesor of Ob& Gyn

F.Behnamfar Gynecology Oncology Fellow Professor

Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women E. Riva, D. Serraino,

Cytopathology Challenge!

The most common origin of cervical squamous cell carcinoma

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Volume 148, Issue 1, Pages (January 2018)

QUIZ QUESTIONS 1) WHAT ARE THE TWO TYPES OF CERVICAL CANCER?

معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia A. Gradíssimo Oliveira, C. Delgado,

Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions.

Female Reproductive System

Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer Med Princ Pract - DOI: /

Volume 149, Issue 3, Pages (June 2018)

Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia A. Gradíssimo Oliveira, C. Delgado,

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Management of the Abnormal Pap Smear.

Volume 5, Issue 1, Pages e45-e58 (January 2018)

SBÜ KAYSERİ ERH Doç. Dr. Gökhan Açmaz

Public Health England leads the NHS Screening Programmes

Volume 136, Issue 2, Pages (February 2015)

AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist

Figure 1: Guidelines for primary cytology# screening in South Africa

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Cervical excisional treatment of young women: A population-based study

SH-sheikhhasani Gyn-oncologist

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis Chunqing Lin,

Downgrading -IN 2, Diagnoses and Predicting Higher-grade Lesions

Volume 153, Issue 1, Pages (April 2019)

Programmatic human papillomavirus testing in cervical cancer prevention in the Jujuy Demonstration Project in Argentina: a population-based, before-and-after.

Demographics of study participants and reasons for declining participation. CIN2+, cervical intraepithelial neoplasia grade 2+; GCSE, General Certificate.

Fig. 3. The relationship between the TTD of the initial treatment and RFS following the repeated treatment. (A, C) AEH and (B, D) early G1. AEH, atypical.

Fig. 3. The examinations consumed by the three cervical screening strategies to detect CIN2+/CIN3+. (A) The cases of CIN2+ detected by three current cervical.

Fig. 2. Three cervical screening strategies to detect CIN2+/CIN3+

Presentation transcript:

Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LEEP, loop electrosurgical excision procedure; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy; PCR-RDB, polymerase chain reaction-reverse dot blot; TCT, thinprep cytologic test. *HR-HPV (+): including HPV-16/-18 (+) (n=1,336) and HR-HPV non-16/18 (+) (n=2,599). Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LEEP, loop electrosurgical excision procedure; LSIL… J Gynecol Oncol. 2019 May;30(3):e29. https://doi.org/10.3802/jgo.2019.30.e29